Comprehensive listing of Brain Stimulation events, conferences, workshops, and webinars.
Overview The Brain stimulation journal will be having a monthly journal club on recently published work on the journal to initiate discussion on important topics in the field. This month, the journal club will be taking place on Wednesday, Oct 6th, at 10 AM ET. The event is free and on zoom but needs registration. The October journal club theme will be on Individualized non-invasive brain stimulation. The outline of the meeting is as follows: Opening remarks: Mark George, Editor in chief of Brain Stimulation Journal, Marom Bikson, Deputy Editor of Brain Stimulation Journal Speakers: Carys Evans, University College of London (15 min) Paper: Dose-controlled tDCS reduces electric field intensity variability at a cortical target site Aprinda Indahalastari, University of Florida (15 min) Paper: Individualized tDCS modeling predicts functional connectivity changes within the working memory network in older adults Kevin Caulfield, Medical University of South Carolina (13 min) Paper: Transcranial electrical stimulation motor threshold can estimate individualized tDCS dosage from reverse-calculation electric-field modeling Q&A section (15 min)
Oct. 6, 2021 10:00 AM (ET)
Overview The three-day course offers intensive training on Transcranial Magnetic Stimulation (TMS). TMS is an FDA-cleared treatment for depression, obsessive-compulsive disorder, migraines, smoking cessation and cortical mapping. This course is designed for psychiatrists, psychologists and researchers who wish to enhance their knowledge of TMS and related brain stimulation techniques, and includes didactic sessions and hands-on administration of TMS. The didactic sessions cover all topics relevant to running a TMS clinical service and a TMS research lab, including: Device principles and types; the neuroscience of TMS Motor threshold determination Treatment technique Stimulus dosing Risks, complications and contraindications Safety screening Post-TMS management and continuation treatment Clinical and non-clinical research applications Emerging brain stimulation techniques Learning Objectives At the conclusion of this course, participants should be able to: State the rationale for the use of TMS in depression, obsessive compulsive disorder and off-label conditions Explain regulatory issues and policies concerning TMS Name the two main components of transcranial magnetic stimulation devices Operate the TMS device and correctly use it to determine the optimal site and motor threshold Describe the findings from TMS research in imaging and motor cortex excitability studies Apply the indications for use of TMS in depression Identify the risks and side effects of TMS and describe how to conduct a safety screening Design a protocol for seizure management during TMS administration Outline steps necessary to set up a TMS service/lab Schedule, Cost, & Registration The course, currently offered on a quarterly basis, is held on a Saturday from 8:30am to 5pm, Sunday from 8:30 am to 7pm and Monday from 8:30am to 5pm. Attendees must attend all three days of the course in order to receive full continuing education credit for the course. The 2021 courses are being offered virtually due to COVID-19. The cost of the course is $2,700 and the course is capped at 30 participants. Faculty Greg Appelbaum, PhD Adjunct Professor of Psychiatry & Behavioral Sciences Duke University School of Medicine Dr. Greg Appelbaum, an associate professor in the Department of Psychiatry & Behavioral Sciences in the Duke University School of Medicine, directs the Human Performance Optimization lab (OptiLab) and the Brain Stimulation Research Center. He is a core member of the Center for Cognitive Neuroscience, holds a secondary appointment in the Department of Psychology and Neuroscience, and teaches graduate and undergraduate students in the Cognitive Neuroscience Admitting Program and the neuroscience major. Dr. Appelbaum’ s research interests primarily concern neuroplasticity and learning using an assortment of human neuroscience techniques including electroencephalography (EEG), functional magnetic resonance imaging (fMRI), transcranial magnetic stimulation (TMS), and transcranial electrical stimulation (TES). This research is funded by the National Institutes of Health and the Department of Defense with the specific goal of translating basic science knowledge to applications that can improve human behavior and brain health. Asa Cordle, MD Partner, Raleigh Psychiatric Associates TMS Clinic Director Inspired by an optimism for the clinical applications of neurotechnology, Dr. Asa Cordle has supplemented much of his medical career practicing, teaching or researching brain stimulation modalities in academic and private clinical settings. While at UNC-Chapel Hill for medical school and psychiatry residency, he trained in ECT and assisted with research in DBS and transcranial current stimulation. He then completed a fellowship at MUSC's Brain Stimulation Service, treating patients and supervising trainees in TMS and ECT. As a psychiatrist at Raleigh Psychiatric Associates, he has treated hundreds of patients with TMS as well as offered more conventional services to general psychiatry outpatients. In addition to neurostimulation, he also has interests in psychotherapy and longevity medicine and continues to train local colleagues in TMS He is excited about the continued progress seen with TMS and brain stimulation in complementing psychiatry's array of therapeutic approaches. Simon W. Davis, PhD Assistant Professor, Department of Neurology Duke University School of Medicine Dr. Simon Davis received his BA from New College of FL, an MSc in Neuropsychology from University College London, and a PhD in Psychology & Neuroscience from Duke University. His lab at Duke specializes in structural, functional, and causal approaches to the investigation of the dynamics of the normal and demented aging brain. Leah D. Frymi, MD Staff Psychiatrist Durham VA Medical Center Dr. Leah Fryml earned her MD at the Medical University of South Carolina (MUSC) in Charleston, South Carolina. After graduating, she completed a residency in psychiatry (Interventional Psychiatry Research Track) at MUSC, where, under the tutelage of Dr. Mark George, innovator and pioneer of transcranial magnetic stimulation therapy for depression, she received intensive training in research and clinical applications of rTMS and ECT. Following residency, she served as the medical director for the Carolina Center for Neurostimulation and interim medical director for the Clinical TMS Service while on the clinical faculty at University of North Carolina-Chapel Hill. In her current role as staff psychiatrist at the VA Medical Center in Durham, NC, she supervises Duke psychiatry residents and trainees while providing inpatient psychiatric and ECT services and working to expand veteran access to interventional treatments, including rTMS, infusions, and intranasal esketamine. Tommy G. Fu, MD Psychiatrist Professor Department of Cancer Biology at Wake Forest University Health Sciences Dr. Tommy Fu received his BA in biological sciences with concentration in animal physiology from Cornell University and his MD from SUNY Upstate Medical University. He recently completed his general psychiatry residency at the Medical University of South Carolina in June 2020. During his last year of residency, he was fortunate enough to work extensively with the brain stimulation group at MUSC on clinical services. He also attended MUSC’s Brain Stimulation Intensive Course in 2019 directed by Dr. George. Dr. Fu is trained in both TMS and ECT. He is a member of the Clinical TMS Society. Colleen A. Hanlon, PhD Adjunct Professor of Psychiatry & Behavioral Sciences Duke University School of Medicine Dr. Colleen A. Hanlon is a professor in the Department of Cancer Biology at Wake Forest University Health Sciences, where she leads a new Electromagnetic Therapeutics Research Program. The majority of her research is focused on developing evidence-based TMS protocols which may be useful therapeutic tools for patients struggling with addiction. She leads 3 NIH-supported R01 awards and is part of two NIH centers interested in translating preclinical brain stimulation knowledge into a treatment that can be delivered to patients with alcohol and substance use disorders. She was honored with the Early Career Investigator award from the National Institute of Drug Abuse. I am the senior author on the first “Consensus Paper” published by a group of more than 70 scientists from more than 10 countries outlining the path forward for Non-Invasive Therapeutic Development for Addiction. She participates in the research training and education community at both a local level (serving as a mentor to over 50 medical, graduate, post-graduate, and fellowship trainees since 2005 on a national and international scale) and national level. She has directed the Advanced TMS Training Course sponsored by the National Center for Neuromodulation for Rehabilitation, and continues to be involved in their research dissemination efforts through teaching and management of their social media presence. She has led an annual addiction outreach event at the College of Problems on Drug Dependence (CPDD) meeting (2015-2019), served on the Liaison Committee (2016-2019) and the Education and Training Committee (2019-present) for the American College of Neuropsychopharmacology, Grassroots Advocacy Team for the Society for Neuroscience (2017-2019), Chair of the Education Outreach and Public Policy Committee for CPDD (2017-2019), ad hoc participation in over 20 NIH study sections, and serving as a standing member of NIH NPAS study section (effective 10/2018). Bruce M. Luber, PhD Staff Scientist, National Institute of Mental Health Dr. Bruce Luber received his PhD in experimental psychology from NYU, researching spatial attention using magnetoencephalopgraphy (MEG). His post-doctorate work at Columbia University/NY State Psychiatric Institute focused on the electrophysiology of memory and of ECT. He joined Dr. Holly Lisanby in the then new field of transcranial magnetic stimulation (TMS) at Columbia in 1995. With Dr. Lisanby and collaborators he researched the cortical mechanisms underlying working memory, conditioned learning, pain, deception, and self-recognition. His primary focus is on the use of TMS to explore executive function and memory, and its applications to geriatric psychiatry and to major depression. He was on the faculty at Columbia University until November 2010 when he moved to Duke University. In 2015, he moved to the NIMH in Bethesda, MD. Shawn M. McClintock, PhD, MSCS Associate Professor Division of Psychology, Department of Psychiatry UT Southwestern Medical Center Adjunct Associate Professor Department of Psychiatry & Behavioral Sciences Dr. Shawn McClintock received his BA in psychology from the University of North Texas (1998), his MS in Rehabilitation Counseling Psychology (2005), PhD degree in Clinical Psychology (2006), and his MS in Clinical Sciences (2011) from UT Southwestern Medical Center. He completed postdoctoral training in clinical neuropsychology and mood disorders research as a National Institute of Mental Health T32 Postdoctoral Fellow at UT Southwestern Medical Center, and he completed postdoctoral training in brain stimulation and therapeutic modulation at Columbia University / New York State Psychiatric Institute. Dr. McClintock’s program of research has centered around elucidating the mechanisms underlying the neurocognitive effects of major depressive disorder and neuromodulation therapeutics including electroconvulsive therapy (ECT), magnetic seizure therapy (MST), transcranial magnetic stimulation (TMS), and transcranial direct current stimulation (tDCS). Andrada D. Neacsiu, PhD Assistant Professor Director of Behavioral Medicine Department of Psychiatry & Behavioral Sciences Department of Family Medicine and Community Health Duke University Medical Center Dr. Andrada Neacsiu is a clinical psychologist with a primary interest in outpatient interventions for difficulties managing emotional experiences that interfere with well-being. As a clinician, she specialize in Dialectical Behavior Therapy (DBT) and Cognitive Behavioral Therapy (CBT) for adults who report a variety of mental health problems, including personality, mood, anxiety, eating, trauma, stress-related, adjustment, and impulse control disorders. Her approach to psychotherapy includes working collaboratively with patients to identify their unique life and therapy goals and to implement evidence-based interventions in order to achieve their identified goals. As an educator, she trains clinicians nationally and teaches Duke graduate students, psychology and psychiatry residents in in how to effectively apply CBT and DBT in their clinical work. She also directs a wellness program in the department of Family Medicine and Community Health. As a researcher, she focuses on psychotherapy optimization and neuroscience-informed treatment development for emotion dysregulation. Her research keeps her up to date with the latest evidence-based approaches to use in her clinical work, and her work with patients strongly influences the research that she does. Outside of work, she enjoys traveling, gourmet food, nature adventures and time with friends and family. Angel V. Peterchev, PhD Associate Professor Department of Psychiatry & Behavioral Sciences Division of Behavioral Medicine & Neurosciences Departments of Biomedical Engineering, Electrical & Computer Engineering, and Neurosurgery (secondary) Duke University Dr. Angel Peterchev received an AB degree in physics and engineering sciences from Harvard University in 1999 and MS and PhD degrees in electrical engineering with a graduate-level minor in cognitive neuroscience from the University of California at Berkeley in 2002 and 2005, respectively. He completed postdoctoral training in TMS at Columbia University in 2007, and remained on the faculty there until the end of 2010, when he moved to Duke University. Dr. Peterchev’ s current research focuses on the development and modeling of technology and application paradigms for transcranial brain stimulation, including TMS, electroconvulsive therapy (ECT), magnetic seizure therapy (MST), and the integration of TMS with functional magnetic resonance imaging (fMRI) and electroencephalography (EEG). The ultimate clinical goal of his work is to make transcranial stimulation techniques robustly effective and safe. Sandeep Vaishnavi, MD, PhD Medical Director, MindPath Care Centers Brain Stimulation Program and Medical Director, MindPath Care Centers Clinical Research Institute Dr. Sandeep Vaishnavi received his MD and PhD from the University of Alabama at Birmingham. He did his residency in psychiatry at Duke University, as well as a Clinical Psychopharmacology residency at Duke University and GlaxoSmithKline. He did his fellowship in behavioral neurology & neuropsychiatry at Johns Hopkins. Dr. Vaishnavi is board-certified in behavioral neurology & neuropsychiatry, as well as general psychiatry. He is the coauthor of The Traumatized Brain (Johns Hopkins University Press, 2015). He is interested in the interface of neurology and psychiatry (mood, behavioral, and cognitive symptoms in neurological disorders, including traumatic brain injury, brain tumor, and stroke). He is also interested in studying and using biomarkers, objective assessments and neuroscience-based treatments for psychiatric disorders. Ellie Wood Clinical Research Specialist, Sr. Department of Psychiatry & Behavioral Sciences, Division of Behavioral Medicine and Neurosciences Duke University School of Medicine Ellie Wood recently earned her BSE in Biomedical Engineering with concentrations in Electrobiology and Biomedical Imaging and Instrumentation from Duke University’s Pratt School of Engineering. Ms. Wood serves as a TMS technician for the Duke University School of Medicine’s Brain Stimulation Research Center, where she collaborates with researchers who are looking to explore potential applications of TMS in the fields of psychiatry, neurology and psychology. She also serves as a clinical research coordinator for the Human Performance Optimization lab (OptiLab), which focuses largely on innovative approaches for accelerating and learning and remediating deficits. Jonathan R. Young, MD VA Advanced Fellow in Mental Illness Research and Treatment, Mid-Atlantic MIRECC Research Fellow, Duke Clinical Research Institute (DCRI) Clinical Associate, Division of Behavioral Medicine & Neurosciences Department of Psychiatry & Behavioral Sciences Duke University School of Medicine Dr. Jonathan Young received his BA in psychology, physics and chemistry from New York University in 2010 and his MD from Stony Brook University in 2016. He completed his residency in adult psychiatry at Duke University Health System in 2020. Dr. Young began working in clinical neuroscience as an undergraduate research assistant under Thomas Thesen, PhD, where he administered functional magnetic resonance imaging (fMRI) and published on the default mode network abnormalities in idiopathic generalized epilepsy. During medical school, Dr. Young became a visiting graduate student at Duke under Sarah Lisanby, MD where he contributed to mood disorders clinical trials using transcranial magnetic stimulation (TMS), transcranial direct current stimulation (tDCS), and electroconvulsive therapy (ECT). As a resident at Duke, he published on novel applications of non-invasive brain stimulation (NIBS) including the treatment of opioid use disorder (OUD) and the enhancement of surgical skills training. During this time he received awards from the Society of Biological Psychiatry (SOBP), International Society of ECT and Neurostimulation (ISEN), and the American Society of Clinical Psychopharmacology (ASCP). Currently an attending psychiatrist for the Duke ECT program, Dr. Young is also research fellow at the Durham VA Medical Center under the mentorship of Jean Beckham, PhD, and Greg Appelbaum, PhD, exploring the therapeutic application of fMRI-guided TMS for the treatment substance use disorders in Veterans with comorbid psychiatric illness. Faculty The following speakers and/or planning committee members have indicated they have no relationship(s) with industry to disclose relative to the content of this CME activity: Lawrence Appelbaum, PhD Asa Cordle, MD Simon Davis, PhD Tommy Fu, MD Sarah H. Lisanby, MD Bruce Luber, PhD Marisa Spurrell, BA Jonathan Young, MD The following speaker/planning committee member have indicated that s/he has relationship(s) with industry to disclose: Stefan Goetz, PhD, investigator for Magstim. Stock holder in Nervive. Colleen A. Hanlon, PhD, consultant for Roswell Park Cancer Institute. Shawn M. McClintock, PhD, MSCS, consultant for X-Pearson Assessment. Andrada Neacsiu, PhD, has received training fees for teaching mental health providers cognitive behavioral therapy and dialectical behavioral therapy techniques from Behavioral Tech and NC AHECs. Angel V. Peterchev, PhD, is inventor on patents and patent applications and has received research and travel support as well as patent royalties from Rogue Research, research and travel support, consulting fees, as well as equipment loan from Tal medical, patent application support from Magstim, as well as equipment loans from MagVenture, all related to technology for TMS. Sandeep Vaishnavi, MD, PhD, employee of MindPath Care Centers, primary investigator for Otsuka, primary investigator for National Institute of Child Health and Human Development, and consultant for the Department of Defense. To learn more, contact Marisa Spurrell at DukeTMS@dm.duke.edu or 919-681-0935
Oct. 16 - 18, 2021
Central Nervous System Injury and Repair by the Gordon Research Conference Conference Program: Non-Mammalian Animal Models of Axonal Injury Discussion Leaders · Britta Eickholt (Institute of Biochemistry, Charite – Universitätsmedizin Berlin, Germany) Speakers · Catherina Becker (University of Edinburgh, United Kingdom) · Marc Hammarlund (Yale University, USA) · Melissa Rolls (Pennsylvania State University, USA) Axon Growth and Guidance in Development and Injury Discussion Leaders · Frank Bradke (German Center for Neurodegenerative Diseases, Germany) Speakers · Florence Bareyre (Ludwig-Maximilians-Universität München, Germany) · Zhigang He (Harvard Medical School, USA) · Kevin Park (The University of Miami, USA) Cell-Cell Communication: Local Inflammatory and Non-Inflammatory Post-Injury Responses Discussion Leaders · Binhai Zheng (University of California, San Diego, USA) Speakers · Phillip Popovich (The Ohio State University College of Medicine, USA) · Hongyan Zou (Icahn School of Medicine at Mount Sinai, USA) Mechanisms of Injury-Dependent Pain and Nociception Discussion Leaders · Armin Blesch (University of California, San Diego, USA) Speakers · Victoria Abraira (Rutgers University, USA) · Alexander Chesler (National Institutes of Health, USA) · Stephen McMahon (King’s College London, United Kingdom) Metabolic Changes and Microbiome in the Context of Nervous System Injury Discussion Leaders · Alyson Fournier (McGill University, Canada) Speakers · Zu-Hang Sheng (National Institute of Neurological Disorders and Stroke, NIH, USA) Neurocircuitry and Neurostimulation After Spinal Cord Injury Discussion Leaders · Jack Martin (City University of New York School of Medicine, USA) Speakers · Polina Anikeeva (Massachusetts Institute of Technology, USA) · Gregoire Courtine (Swiss Federal Institute of Technology Lausanne (EPFL), Switzerland) · Martin Schwab (University of Zurich, Switzerland) · Aya Takeoka (KU Leuven / VIB, Belgium) Neurotechnologies and Novel Approaches Discussion Leaders · Hongyan Zou (Icahn School of Medicine at Mount Sinai, USA) Speakers · Madeline Lancaster (MRC Laboratory of Molecular Biology, United Kingdom) · Jae Lee (University of Miami, USA) · Joost Verhaagen (Netherlands Institute for Neuroscience, The Netherlands) Cell-Based Strategies for Therapy Discussion Leaders · Michael Sofroniew (University of California, Los Angeles, USA) Speakers · Magdalena Goetz (Biomedical Center Munich, Ludwig Maximilian University of Munich, Germany) · Guo-Li Ming (University of Pennsylvania, USA) · Mark Tuszynski (University of California, San Diego, USA) Clinical Translation in Spinal Cord Injury Discussion Leaders · Jan Schwab (The Ohio State University College of Medicine, USA) Speakers · Azad Bonni (F. Hoffmann-La Roche, Switzerland) · Michael Fehlings (University of Toronto, Canada) · Margaret Purcell (University of Glasgow, United Kingdom)
Oct. 17 - 22, 2021
Number of participants 30 maximum Dates 20-22 October 2021 Make sure to select the date with the (London, UK) addition Location Academy of Medical Sciences 41 Portland Place London, United Kingdom Target group Clinicians, Health Care Professionals, and Researchers Registration fee € 1500,- Further information firstname.lastname@example.org Researchers, Clinicians, and Academics from Maastricht University provide the renowned International TMS Certification Course to be held in London, UK with a focus on the clinical applications of Transcranial Magnetic Stimulation (TMS). This Intensive 3 FULL-DAY Course is industry-independent, taught in English, in an academic environment, by internationally renowned experts in the field of noninvasive brain stimulation. Training is available on various TMS systems, including additional equipment for TMS Neuronavigation, and the combination of TMS with fMRI, EEG, and EMG. The course is characterised by a strong focus on intensive practical hands-on training. Basic and advanced training options will be available to offer both, basic training for beginners but also advanced training for more experienced participants. After learning how to apply TMS theoretically, participants enjoy workshops in our actual TMS labs. Here they are instructed in the everyday operation of the machinery, and both administer and experience different stimulation protocols. They determine individual thresholds of excitability, and learn how to programme TMS machines. This provides them with all the tools to administer TMS in both research and clinical therapy. Instruction also includes extensive lessons and discussion on safety procedures and regulations. The course also includes a module on transcranial electric brain stimulation (TCS), covering principles and application examples of direct current (TDCS), alternating current (TACS), and random noise (TRNS) stimulation protocols.
Oct. 20 - 22, 2021
Overview Speakers: Lorenzo Rocchi - Disentangling EEG responses to TMS due to cortical and peripheral activations Pedro Gordon - Modulation of cortical responses by transcranial direct current stimulation of dorsolateral prefrontal cortex: A resting-state EEG and TMS-EEG study Sina Shirinpour - Experimental evaluation of methods for real-time EEG phase-specific transcranial magnetic stimulation The event is Free. Registration is required.
Oct. 20, 2021 10:00 AM (ET)
At the 2nd International Congress on Neuroscience and Rehabilitation We want to promote a rich discussion on how research and development in neuroscience has improved the accuracy of diagnostic and treatment tools, enhancing results and making clinical care increasingly personalized and focused on quality of life of patients in functional, neuropsychological and social rehabilitation. To fulfill this objective in a multi and interdisciplinary way, the Neuronus Institute invited some of the most impactful researchers and professionals from Brazil and the world and from different areas of knowledge, who have been engaged in the research, development and clinical applications of these tools to bring a current perspective and a look to the future on neuroscience and rehabilitation. Speakers ALEX FORNITO - Monash University ANDREA ANTAL - Georg-August-Universitat Gottingen ANDREW BATEMAN - University of Essex ANTÔNIO MARTINS MOURÃO - London Scientific BARBARA WILSON - Oliver Zangwill Centre BRAD MANOR - Harvard Medical School DIANA MARTINEZ - Boston NeuroDynamics ERIK PEPER - Biofeedback Health LARA PIERCE - York University LEW LIM - Vielight Medical LYNDA THOMPSON MAROM BIKSON - The City College of New York MICHAEL NITSCHE - iFADO Leibniz Institute MICHEL THIEBAUT - Bordeaux Neurocampus MÓNICA PISTOIA - CoNoCe Frederico II University - Italy PAUL FITZGERALD - Monash University PAUL G. SWINGLE - Swingle Clinic SANTIAGO BRAND - The MindLab YURY KROPOTOV - Institute of The Human Brain ADRIANA FOZ - Neuroconecte/LINC - UNIFESP ADRIANO MOFFA - University of New South Wales ÁGUIDA FOERSTER - Neuro-Centrum Düsseldorf ALEXANDRE OKANO - UFABC ALFREDO SIMONETTI - São Camilo Medical School
Oct. 23 - 24, 2021
Number of participants 30 maximum Dates 29 November – 1 December 2021 When registering, make sure you select the dates with the (Amsterdam, NL) addition. Location Hotel Casa, Amsterdam The Netherlands Target group Clinicians, Health Care Professionals, and Researchers Registration fee € 1500,- Further information email@example.com Researchers, Clinicians, and Academics from Maastricht University provide the renowned International TMS Certification Course to be held in Amsterdam, NL with a focus on the clinical applications of Transcranial Magnetic Stimulation (TMS). This Intensive 3 FULL-DAY Course is industry-independent, taught in English, in an academic environment, by internationally renowned experts in the field of noninvasive brain stimulation. Training is available on various TMS systems, including additional equipment for TMS Neuronavigation, and the combination of TMS with fMRI, EEG, and EMG. The course is characterised by a strong focus on intensive practical hands-on training. Basic and advanced training options will be available to offer both, basic training for beginners but also advanced training for more experienced participants. After learning how to apply TMS theoretically, participants enjoy workshops in our actual TMS labs. Here they are instructed in the everyday operation of the machinery, and both administer and experience different stimulation protocols. They determine individual thresholds of excitability, and learn how to programme TMS machines. This provides them with all the tools to administer TMS in both research and clinical therapy. Instruction also includes extensive lessons and discussion on safety procedures and regulations. The course also includes a module on transcranial electric brain stimulation (TCS), covering principles and application examples of direct current (TDCS), alternating current (TACS), and random noise (TRNS) stimulation protocols.
Nov. 29 - Dec. 1, 2021
Topics will include: Animal models Closed-loop or responsive stimulation Combining brain stimulation methods with brain imaging Computer modeling of brain stimulation methods Deep brain stimulation (DBS) EEG-synchronization Electroconvulsive therapy (ECT) Focal pharmacology Neuronavigation Neurophysiology Novel neuromodulation techniques Plasticity of the nervous system Transcranial alternating current stimulation (tACS) Transcranial direct current stimulation (tDCS) Transcranial magnetic stimulation (TMS) Transcranial pulsed ultrasound (tPUS) Vagus nerve stimulation (VNS) Basic neuroscience Clinical neurological applications Clinical psychiatric applications Cognitive and affective neuroscience
Dec. 7 - 10, 2021
May 11 - 14, 2022
Congress Chair Carlos Tornero, MD, PhD Congress Co-Chair David Abejon, MD, PhD Local Organizing Committee Chair: Gloria Villalba Martinez, MD Innovations in Neuromodulation Elliot Krames, MD Marc Russo, MBBS, DA Carlos Tornero, MD, PhD Scientific Program Co-Chair Elliot Krames, MD Scientific Program Co-Chair Fabian Piedimonte, MD Scientific Program Section Co-Chairs Basic Science Robert Foreman,PhD Bert Joosten, PhD Neuroprosthetics and Neural Engineering Jin Woo Chang, MD, PhD Joe Pancrazio, PhD Socioeconomics Sam Eldabe, MBBS Rod Taylor, PhD Brain: Movement Disorders Fabian Piedimonte, MD Jan Vesper, MD, PhD Brain: Psychiatric Disorders Andre Machado, MD, PhD Andres Lozano, MD, PhD Brain: Epilepsy Arthur Cukiert, MD, PhD Kristl Vonck, MD, PhD Brain: Neurorehabilitation Julian Taylor, PhD Felipe Fregni, MD, PhD, MPH, Med Brain: Non-Invasive Stimulation Eric Wassermann, MD Brain: Computer Interface / Artificial Intelligence Jeff Arle, MD, PhD Nader Pouratian, MD, PhD Spinal Cord: Pain Julie Pilitsis, MD, PhD Philippe Rigoard, MD, PhD Spinal Cord: Intrathecal Drug Delivery for Pain Christophe Perruchoud, MD Tony Yaksh, PhD Spinal Cord: Spasticity Michael Saulino, MD, PhD Alessandro Dario, MD Spinal Cord: Functional Restoration Jocelyne Bloch, MD Peter Konrad, MD, PhD Spinal Cord: Cardiovascular Disorders Mike DeJongste, MD, PhD Monique Steegers, MD, PhD Peripheral Nerve: Headache Sam Narouze, MD, PhD Nagy Mekhail, MD Peripheral Nerve: Pain Frank Huygen, MD, PhD Nick Boulis, MD Peripheral Nerve: Gastrointestinal Disorders Thomas Abell, MD Jiande Chen, PhD Genitourinary Disorders Sean Francis, MD Stefan De Wachter, MD, PhD Peripheral Nerve: Systemic Disease Peter Staats, MD, MBA Jeffrey Ardell, PhD Allied Health Workshop on Neuromodulation Caro Edelbroek, MANP, MAMB Rachel Whipp, RN BNurs. General Scientific Program Committee G. Baranidharan, MBBS Jose De Andres, MD, PhD Jose Antonio Lopez Lopez, MD, PhD
May 21 - 26, 2022
Topics that will be included in the program: Acquired Brain Injury Rehabilitation Community, Vocational and Tele-Rehabilitation (including rural and remote) Disaster Management Innovation and Technology Musculoskeletal Rehabilitation Neurological Rehabilitation Older Persons’ Rehabilitation Other (eg Cancer Rehabilitation, Bariatric Rehabilitation, Burns Rehabilitation) Paediatric Rehabilitation and Transition Pain Rehabilitation Private Practice Prosthetics and Orthotics Rehabilitation Research Service development & model of care Spinal Injury Rehabilitation Stroke Rehabilitation
Jun. 7 - 10, 2022
Hosted by: World Society for Stereotactic and Functional Neurosurgery Program and speakers to be announced
Sep. 4 - 7, 2022
About INS-IM 2021 Gateway to the world of Neuromodulation – INS-IM 2021 Greetings from the secretariat of INS-IM 2021 In the past several months lot of things have happened the most notable being COVID-19 pandemic and how it has disrupted over lives. We were scheduled to have our International Neuromodulation Society Interim Meeting in October 2020 and after careful deliberations with the INS Leadership we have moved it to November 2021. The tentative dates are from 19th to 21st November 2021. I am happy to inform that we have been able to get the confirmation from most of our faculty for the 2021 dates as well. In a way, this has provided us with a unique opportunity to put our best foot forward. I would encourage all of you to prepare and submit your papers online. Those of you have registered for the meeting, their registrations will be carried forward. During this time The Neuromodulation Society has also been strengthened and has launched the website: www.neuromodulationsociety.in and various educational activities. I look forwards to your suggestions and comments, which you can write back on @ firstname.lastname@example.org. With warm regards, Dr. Paresh Doshi Chairman INS-IM 2020 Organising Committee Dr. Paresh Doshi Chairman Dr. Vijayanand Palanisamy Organising Secretary Dr. Preeti Doshi Organising Secretary Dr. Amit Desai Psychiatrist Dr. Krishna Poddar Pain Physician Dr Ravi Varma Neurosurgeon Dr. Shailesh Raina Urologist Dr. Dwarakanath Srinivas Neurosurgeon Dr. Muralidhar Joshi Pain Physician Dr. Samir Desai Pain Physician Dr. Sudhir Shah Neurologist Dr. Joy Desai Neurologist Dr. Pettarusp Wadia Neurologist Dr. Sandeep Vaishya Neurosurgeon Dr. Kailash Kothari Pain Physician Dr. Pramod Pal Neurologist Dr. Sangita Das Pain Physician Keynote Speakers Dr. Ted Kaptchuk Professor of Medicine United States Keynote: “Placebo Effects in Medicine” Dr. Marc Russo Pain Physician, President elect, INS Australia Keynote: “Delivering neuromodulation in an Emerging Economy” Dr. Robert Levy Neurosurgeon, President, INS United StatesKeynote: “Cortical stimulation for motor recovery” Dr. Konstantin Slavin Neurosurgeon, Secretary, INS United StatesKeynote: “Evolution of Neuromodulation in the next decade: As I see” Dr. Timothy Deer Pain Physician, Past President, INS United StatesKeynote: “Work life balance: From Ironman to INS president” Dr. Ali Rezai Neurosurgeon, Vice President of Neuroscience, Associate Dean, WVU United StatesKeynote: “Chronic pain sensing, Monitoring and Analytics to improve neuromodulation therapies” International Faculty Dr. Robert Levy Neurosurgeon; President, INS United States Dr. Konstantin Slavin Neurosurgeon; Secretary, INS United States Dr. Jan Vesper Neurosurgeon; Treasurer, INS Germany Dr. Ted Kaptchuk Professor of Medicine United States Dr. Timothy Deer Pain Physician Past President, INS United States Dr. Robert D Foreman Pain Physician Acting Editor-in-Chief, Neuromdoulation United States Dr. Marc Russo Pain Physician President elect, INS Australia Dr. Jin Woo Chang Neurosurgeon; President, WSSFN Korea Dr. Sudhir Diwan Pain Physician; President, ASIPP United States Dr. Joachim Krauss Neurosurgeon Past President, WSSFN Germany Dr. Mojgan Hodaie Neurosurgeon Vice Secretary, WSSFN Canada Dr. Michael Schulder Neurosurgeon Past President, WSSFN United States Dr. Yong Chul Kim Pain Physician Korea Dr. Byung-Chul Son Neurosurgeon; Chapter president, INS Korea Dr. Guoming Luan Neurosurgeon; Chapter president, INS China Dr. Hidehiro Hirabayashi Neurosurgeon; Chapter president, INS Japan Dr. Nick Christelis Pain Physician; President, NSANZ Australia Dr. Elena Moro Neurologist France Dr. Ali Rezai Neurosurgeon Vice President of Neuroscience, Associate Dean, WVU United States Dr. Lawrence Poree Pain Physician DAL-INS United States Dr. Dharam Mann Pain Physician United States Dr. Ganesan Baranidharan Pain Physician United Kingdom Dr. Arun Bhaskar Pain Physician United Kingdom Dr. Mayank Gupta Pain Physician United States Dr. Prof Sam Eldabe Pain Physician United Kingdom Dr. Ashish Gulve Pain Physician United Kingdom Dr. Vivek Mehta Pain Physician United Kingdom Dr. Kailash Bhatia Neurologist United Kingdom Dr. Richard Sullivan Pain Physician Australia Dr. Adnan Al-Kaisy Pain Physician United Kingdom Dr. Jens Volkman Neurologist Germany Dr. Prasad Shirvalkar Neurologist United States Dr. Steven M Falowski Neurosurgeon United States Dr. Vibhor Krishna Neurosurgeon United States Dr. Perminder Sachdev Psychiatrist Australia Dr. Sanjeeva Gupta Pain Physician United Kingdom Dr. Ahmed Alkhani Neurosurgeon Saudi Arabia Dr. Jason Pope MD, DABPM, FIPP, Pain Physician United States Dr. Jeff Arle Neurosurgeon United States Dr. Patric Blomstedt Neurosurgeon Sweden Dr. Schlaepfer Thomas Psychiatrist Germany Dr. Kendal Lee Neurosurgeon United States Dr. Ido Strauss Neurosurgeon Israel Dr. Neel D Mehta Pain Physician United States Dr. Andrea Kuhn Neurologist Germany Dr. Stephen Chabardes Neurosurgeon France Dr. Sameer Sheth Neurosurgeon United States Dr. Anuj Bhatia Pain Physician Canada Dr. Xiongfei Wang Pain Physician China Dr. Emil Isagulyan Neurosurgeon Russia Dr. Faisal Alotaibi Professor Of Neurological Surgery Saudi Arabia Dr. Mike Dejongtse Cardiologist Netherlands Dr. Yeshvant Navalgund Pain Physician United States Dr. Donel Martin Neuropsychologist Australia Dr. Hari Subramanian Scientist United States Dr. Marom Bikson Engineer & Scientist United States Dr. Parag Patil Neurosurgeon United States Dr. Girish Nair Neurosurgeon Australia National Faculty Dr. Paresh Doshi Neurosurgeon; President, TNS; Chairman, INS-IM 2020 Mumbai Dr. Vijayanand Palanisamy Pain Physician; Secretary, TNS; Secretary, INS-IM 2020 Coimbatore Dr. Preeti Doshi Pain Physician; Treasurer, TNS; Secretary, INS-IM 2020 Mumbai Dr. Pramod Pal Neurologist; Board Member, TNS; President, IAN Bengaluru Dr. Amit Desai Psychiatrist; Board Member, TNS Mumbai Dr. Sandeep Vaishya Neurosurgeon; Board Member, TNS Gurugram Dr. Dwarakanath Srinivas Neurosurgeon; Board Member, TNS Bengaluru Dr. Muralidhar Joshi Pain Physician; Board Member, TNS Hyderabad Dr. Sudhir Shah Neurologist Ahmedabad Dr. Charulatta Sankhla Neurologist; President, MDSI Mumbai Dr. Kailash Kothari Pain Physician Mumbai Dr. Krishna Poddar Pain Physician Kolkata Dr. Sangeeta Das Pain Physician Bengaluru Dr. Vihang Vahia Psychiatrist Mumbai Dr. Ravi Varma Neurosurgeon Bengaluru Dr. Asha Kishore Neurologist; President, MDSI Thiruvananthapuram Dr. Mohit Bhatt Neurologist Mumbai Dr. Janardhan Reddy Psychiatrist Bengaluru Dr. Vinay Goyal Neurologist; President Elect, MDSI New Delhi Dr. Aditya Gupta Neurosurgeon; President Elect, ISSFNi Gurugram Dr. Joy Desai Neurologist Mumbai Dr. Guruprasad Hosurkar Neurologist Bengaluru Dr. Prof G Venkatasubramanian Psychiatrist Bengaluru Dr. Shailesh Raina Urologist Mumbai Dr. Babita Ghai Pain Physician Chandigarh Dr. Hammad Usmani Pain Physician Aligarh Dr. Milind Sankhe Neurosurgeon Mumbai Dr. Anandh Balasubramaniam Neurosurgeon Mumbai Dr. Hrishikesh Kumar Neurologist Kolkata Dr. L K Prashanth Neurologist Bengaluru Dr. Malay Dave Psychiatrist Mumbai Dr. Bhaskar Mukherjee Psychiatrist Kolkata Dr. G P Dureja Pain Physician New Delhi Dr. Rajashree Deopujari Anaesthesiologist Mumbai Dr. Sumit Singh Neurologist Gurugram Dr. Pradeep Jain Pain Physician New Delhi Dr. Sushma Bhatnagar Pain Physician New Delhi Dr. Samir Praharaj Psychiatrist Manipal Dr. Shyam Sundar Arumugham Psychiatrist Bengaluru Dr. Pratibha Matche Pain Physician Mysuru Dr. Madhuri Lokapure Pain Physician Pune Dr. Janardhanan Narayanaswamy Psychiatrist Bengaluru Dr. Nand Kumar Psychiatrist New Delhi Dr. Lakshmi Vas Pain Physician Mumbai Dr. Shameem Ahmed Neurosurgeon Guwahati Dr. Sharan Srinivasan Neurosurgeon Bengaluru Dr. Raghuram Neurosurgeon Bengaluru Dr. Pankaj Agrawal Pain Physician Thane Dr. Palak Mehta Pain Physician Ahmedabad Dr. Sudheer Dara Pain Physician Hyderabad Dr. Mahesh Menon Pain Physician Mumbai Dr. Sunita Lawange Pain Physician Nagpur Dr. Karthic Babu Pain Physician Chennai Dr. Pankaj Surange Pain Physician New Delhi Dr. Hitesh Patel Pain Physician Ahmedabad Dr. Shraddha Shah Psychologist Mumbai Dr. Pettarusp Wadia Neurologist; Board Member, TNS Mumbai Call for Abstracts The Scientific Committee invites abstract submissions for INS-IM 2020 to be held from 23rd-25th of October, 2020 at Grand Hyatt, Mumbai, India. The Scientific Committee will consider for acceptance abstracts that have not been previously presented at other national and international scientific meetings. Submitting an abstract does not register you for INS-IM 2020; you must register for the conference. Note: Authors from outside India – Register for the conference at the earliest and apply for a visa. You will need a visa to come to India for the conference. The format of presentation (oral presentation/ePoster) will be decided by the scrutinizing committee from amongst the abstracts received and authors will be informed accordingly. All abstracts must be submitted in English. Step 1: Prepare all the information about your abstract Your abstract must contain: A category A title A list of authors with affiliation of first/presenting author The main text of the abstract, in English Step 2: Select a category and a type of communication Please select one of the following categories for your abstract: Neurosurgery Pain Psychiatry Neurology Others You may also choose the kind of communication you want to be considered for: ePoster presentation OR either oral or ePoster presentations. Step 3: Title The title must be in lowercase with a capital at the beginning. Do not use small capitals or capitals in the title. Do not use asterisks or notes. Your title must be on a single line. Step 4: Authors You must create the list of your authors before submitting your abstracts, and select the first/presenting author. Step 5: Text The text (Body) of the `Abstract’ should contain no more than 250 words. It should be structured as far as possible in the following manner (Except Case Reports): IntroductionAims & Objectives Material & Methods (including statistical methods where relevant) Results Conclusion Please do not enter any special characters, tables or photos in the abstract body. Step 6: Attachment Two images can be attached up to 2 MB size. Step 7: Editing You can edit your submission any time before the last date for submission by clicking on edit on the following link https://ins-im2020.com/track-submission.php The last date for submitting abstracts is 30th June, 2020. Acknowledgment of the receipt of abstract will be sent to your email address along with a tracking number. You can track the status of your submission here: https://ins-im2020.com/track-your-submission.php Certificate will be given to first author/presenter only. For any queries related to abstract submission, please write to email@example.com
Nov. 11 - 13, 2022
December 7 - 10, 2021
Meeting will take place in Charleston, South Carolina. It is a cross-disciplinary meeting which aims provide the opportunity for scientists, clinicians, and engineers of different disciplines to discuss current and possible advances in the field of neuromodulation.
Never miss an event. Sign up to our newsletter for monthly updates.